GSK PLC ADR (GSK) Dividends

GSK Price Forecast Based on Dividend Discount Model

For dividend yielding stocks, the Dividend Discount Model (DDM) is a common valuation tool; it attempts to extrapolate a fair share price based primarily on the dividend the stock provides relative to a number of other quantiative aspects of its business. As for GSK, the DDM model generated by StockNews estimates a return of positive 2499.6% in comparison to its current price. Digging deeper, the aspects of Glaxosmithkline Plc's dividend discount model that we found most interesting were:

• As for its position relative to other Healthcare stocks that issue dividends, Glaxosmithkline Plc offers a higher dividend yield than only 100% of them.
• In terms of opportunity, GSK's provides a return of 2499.6% based on the forecast of the dividend discount model we used relative to its current share price; this is a better return than 96.18% of all stocks we measured with our dividend discount model.

GSK Dividends vs. Peers